Securities
Sep. 2, 2015
Local attorneys to assist in SF biotech company's IPO
In another sign of the life science sector's durability, attorneys from Sidley Austin LLP are advising CytomX Therapeutics Inc. on a planned $100 million initial public offering filed late Friday. Latham & Watkins LLP is advising the under
Daily Journal Staff Writer
In another sign of the life science sector's durability, attorneys from Sidley Austin
LLP are advising CytomX Therapeutics Inc. on a planned $100 million initial public
offering filed late Friday. Latham & Watkins LLP is advising the underwriting syndicate
in connection with the offering.
The South San Franc...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In